The generation of a new human fetal L-MYC-immortalized NSC line is described
These NSCs display self-renewal and can differentiate into neurons and glia
The NSCs can target glioma xenografts and sites of traumatic brain injury in mice
This NSC line may become applicable in therapy of various CNS diseases